Factor VIII analog, preparation process, and pharmaceutical composition containing it
US5112950A · kind A · utility
99Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 1991 |
| Grant date | May 12, 1992 |
| Priority date | — |
| Expiry date | Jun 26, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Factor VIII analog which has undergone deletion of amino acids 771 to 1666, prepared from eukaryotic cells transformed by an expression vector carrying the cDNA of the factor VIII which has undergone deletion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.